Stopping, Continuing, or Restarting Immunomodulators and Biologics When an Infection or Malignancy Develops

Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Trials

(2013) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Increased Risk of Pneumonia Among Patients With Inflammatory Bowel Disease

(2013) Millie D Long et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Lymphoma: The Bête Noire of the Long-term Use of Thiopurines in Adult and Elderly Patients With Inflammatory Bowel Disease

(2013) Laurent Beaugerie   GASTROENTEROLOGY

The management of immunosuppression in patients with inflammatory bowel disease and cancer

(2013) Oren Bernheim et al.   GUT

Safety of Thiopurine Therapy in Inflammatory Bowel Disease

(2013) María Chaparro et al.   INFLAMMATORY BOWEL DISEASES

Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines

(2012) U. Kopylov et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A Pooled Analysis of Infections, Malignancy and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Management of cytomegalovirus infection in inflammatory bowel diseases

(2012) Sylvie Pillet et al.   DIGESTIVE AND LIVER DISEASE

Varicella zoster virus infection in inflammatory bowel disease

(2012) Garret Cullen et al.   INFLAMMATORY BOWEL DISEASES

Clostridium difficile Infection in the Inflammatory Bowel Disease Patient

(2012) Adam M. Berg et al.   INFLAMMATORY BOWEL DISEASES

Risk of Malignancies in Patients With Rheumatoid Arthritis Treated With Biologic Therapy

(2012) Maria A. Lopez-Olivo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease

(2011) J. P. Gisbert et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

(2011) X. Mariette et al.   ANNALS OF THE RHEUMATIC DISEASES

Viral infections associated with the clinical use of monoclonal antibodies

(2011) G. Gentile et al.   CLINICAL MICROBIOLOGY AND INFECTION

Focus on skin cancer association and progression under TNF antagonist therapy

(2011) Claudine Piérard-Franchimont et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease

(2011) Cristina López-Martín et al.   Gastroenterologia y Hepatologia

Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease

(2011) Harminder Singh et al.   GASTROENTEROLOGY

Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: A cohort study

(2011) Mashiko Setshedi et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Review article: explaining risks of inflammatory bowel disease therapy to patients

(2010) C. A. Siegel   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hepatosplenic T-Cell Lymphoma in Inflammatory Bowel Disease: A Possible Thiopurine-Induced Chromosomal Abnormality

(2010) David S Kotlyar et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Risk of Cancer in Inflammatory Bowel Disease Treated With Azathioprine: A UK Population-Based Case–Control Study

(2010) Richard G Armstrong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease

(2010) Filomena Morisco et al.   DIGESTIVE AND LIVER DISEASE

Risk of malignant lymphoma in patients with inflammatory bowel diseases: A Dutch nationwide study

(2010) A. C.W. Vos et al.   INFLAMMATORY BOWEL DISEASES

Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease

(2010) Ashwin N. Ananthakrishnan et al.   INFLAMMATORY BOWEL DISEASES

Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

(2010) W. G. Dixon et al.   ARTHRITIS CARE & RESEARCH

Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT

(2010) Anja Strangfeld et al.   ARTHRITIS RESEARCH & THERAPY

Incidence of benign upper respiratory tract infections, HSV and HPV cutaneous infections in inflammatory bowel disease patients treated with azathioprine

(2009) P. SEKSIK et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials

(2009) G. R. LICHTENSTEIN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

(2009) S. SCHNEEWEISS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease

(2009) M. J. SHALE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Use of Infliximab in Particular Clinical Settings: Management Based on Current Evidence

(2009) Alfredo Papa et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Adverse Events Associated With Common Therapy Regimens for Moderate-to-Severe Crohn's Disease

(2009) Josh Marehbian et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

The implications of anti-tumour necrosis factor therapy for viral infection in patients with inflammatory bowel disease

(2009) M. J. Shale   BRITISH MEDICAL BULLETIN

Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-Analysis

(2009) Corey A. Siegel et al.   Clinical Gastroenterology and Hepatology

Safety Profile of IBD Therapeutics: Infectious Risks

(2009) Waqqas Afif et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2009) J.F. Rahier et al.   Journal of Crohns & Colitis

Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study

(2009) Laurent Beaugerie et al.   LANCET

Efficacy and Safety of Tumor Necrosis Factor Antagonists in Crohn's Disease: Meta-Analysis of Placebo-Controlled Trials

(2008) Laurent Peyrin–Biroulet et al.   Clinical Gastroenterology and Hepatology

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Risk of Cervical Abnormalities in Women With Inflammatory Bowel Disease: A Population-Based Nested Case-Control Study

(2008) Harminder Singh et al.   GASTROENTEROLOGY

Prognosis in Clostridium difficile infection complicating inflammatory bowel disease

(2008) C. D Stone   GUT

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT

Cytomegalovirus infection in ulcerative colitis: A prospective, comparative study on prevalence and diagnostic strategy

(2008) Eugeni Domènech et al.   INFLAMMATORY BOWEL DISEASES

Higher Incidence of Abnormal Pap Smears in Women With Inflammatory Bowel Disease

(2007) Sunanda Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease

(2007) Corey A. Siegel et al.   INFLAMMATORY BOWEL DISEASES